Clonal insulinoma cell line that stably maintains correct glucose responsiveness

David Knaack, Deborah M. Fiore, Manju Surana, Margarita Leiser, Megan Laurance, David Fusco-DeMane, Orion D. Hegre, Norman Fleischer, Shimon Efrat

Research output: Contribution to journalArticlepeer-review

111 Scopus citations

Abstract

A number of pancreatic β-tumor cell (βTC) lines have been derived from insulinomas arising in transgenic mice expressing the SV40 T antigen gene under control of the insulin promoter. Some of these lines secrete insulin in response to physiological glucose concentrations. However, this phenotype is unstable. After propagation in culture, these nonclonal lines become responsive to subphysiological glucose levels and/or manifest reduced insulin release. Here we report the use of soft-agar cloning to isolate single-cell clones from a βTC line, which give rise to sublines that maintain correct glucose responsiveness and high insulin production and secretion for >55 passages (over a year) in culture. One of these clonal lines, denoted βTC6- F7, was characterized in detail. βTC6-F7 cells expressed high glucokinase and low hexokinase activity, similarly to normal islets. In addition, they expressed mRNA for the GLUT2 glucose transporter isotype and no detectable GLUT1 mRNA, as is characteristic of normal β-cells. These results demonstrate that transformed β-cells can maintain a highly differentiated phenotype during prolonged propagation in culture, which has implications for the development of continuous β-cell lines for transplantation therapy of diabetes.

Original languageEnglish (US)
Pages (from-to)1413-1417
Number of pages5
JournalDiabetes
Volume43
Issue number12
DOIs
StatePublished - 1994

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Clonal insulinoma cell line that stably maintains correct glucose responsiveness'. Together they form a unique fingerprint.

Cite this